Morgan Stanley’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$108M Buy
232,302
+5,253
+2% +$2.21M 0.01% 1503
2026
Q1
$85.8M Sell
227,049
-31,784
-12% -$13.6M 0.01% 1575
2025
Q4
$111M Sell
258,833
-90,428
-26% -$39.4M 0.01% 1364
2025
Q3
$156M Buy
349,261
+3,246
+0.9% +$1.47M 0.01% 1078
2025
Q2
$168M Buy
346,015
+32,320
+10% +$18.4M 0.01% 961
2025
Q1
$193M Buy
313,695
+5,581
+2% +$3.17M 0.01% 864
2024
Q4
$163M Sell
308,114
-112,404
-27% -$63.4M 0.01% 937
2024
Q3
$253M Sell
420,518
-13,315
-3% -$7.55M 0.02% 711
2024
Q2
$235M Buy
433,833
+17,996
+4% +$10.3M 0.02% 724
2024
Q1
$267M Buy
415,837
+3,019
+0.7% +$1.83M 0.02% 670
2023
Q4
$241M Buy
412,818
+4,860
+1% +$2.72M 0.02% 693
2023
Q3
$212M Buy
407,958
+4,264
+1% +$2.22M 0.02% 671
2023
Q2
$219M Buy
403,694
+37,487
+10% +$20.5M 0.02% 681
2023
Q1
$197M Buy
366,207
+3,937
+1% +$2.01M 0.02% 702
2022
Q4
$185M Buy
362,270
+230,531
+175% +$112M 0.02% 711
2022
Q3
$57.5M Buy
131,739
+6,086
+5% +$2.93M 0.01% 1219
2022
Q2
$59M Buy
125,653
+86,987
+225% +$42.4M 0.01% 1258
2022
Q1
$19.6M Sell
38,666
-6,279
-14% -$3.01M ﹤0.01% 2136
2021
Q4
$23.8M Buy
44,945
+10,818
+32% +$5.19M ﹤0.01% 1991
2021
Q3
$15.9M Sell
34,127
-21,793
-39% -$10.3M ﹤0.01% 2337
2021
Q2
$26.5M Sell
55,920
-15,093
-21% -$7.25M ﹤0.01% 1864
2021
Q1
$32.7M Buy
71,013
+5,966
+9% +$2.92M ﹤0.01% 1505
2020
Q4
$34.6M Buy
65,047
+34,775
+115% +$17.1M 0.01% 1370
2020
Q3
$14.5M Sell
30,272
-4,907
-14% -$2.41M ﹤0.01% 1709
2020
Q2
$15.9M Sell
35,179
-6,954
-17% -$3.1M ﹤0.01% 1587
2020
Q1
$18.3M Sell
42,133
-204
-0.5% -$91.1K 0.01% 1343
2019
Q4
$18.6M Sell
42,337
-31,764
-43% -$13.4M ﹤0.01% 1725
2019
Q3
$30.9M Buy
74,101
+56,136
+312% +$22.9M 0.01% 1167
2019
Q2
$6.48M Sell
17,965
-1,971
-10% -$659K ﹤0.01% 2642
2019
Q1
$6.38M Sell
19,936
-3,394
-15% -$1.04M ﹤0.01% 2474
2018
Q4
$6.61M Sell
23,330
-2,924
-11% -$882K ﹤0.01% 2561
2018
Q3
$8.39M Sell
26,254
-23,778
-48% -$7.58M ﹤0.01% 2595
2018
Q2
$16.1M Buy
50,032
+4,397
+10% +$1.38M ﹤0.01% 1863
2018
Q1
$12.5M Sell
45,635
-2,146
-4% -$569K ﹤0.01% 2126
2017
Q4
$11.6M Sell
47,781
-6,350
-12% -$1.44M ﹤0.01% 2249
2017
Q3
$10.9M Sell
54,131
-39,247
-42% -$7.72M ﹤0.01% 2188
2017
Q2
$19.1M Buy
93,378
+63,756
+215% +$12.7M 0.01% 1577
2017
Q1
$5.41M Sell
29,622
-25,723
-46% -$4.49M ﹤0.01% 2781
2016
Q4
$8.88M Sell
55,345
-16,138
-23% -$2.37M ﹤0.01% 2381
2016
Q3
$10.1M Sell
71,483
-37,976
-35% -$5.29M ﹤0.01% 2001
2016
Q2
$14.9M Sell
109,459
-27,249
-20% -$3.61M 0.01% 1657
2016
Q1
$18.5M Buy
136,708
+9,682
+8% +$1.31M 0.01% 1361
2015
Q4
$19M Sell
127,026
-19,551
-13% -$2.89M 0.01% 1439
2015
Q3
$19.6M Sell
146,577
-7,726
-5% -$1.08M 0.01% 1401
2015
Q2
$20.2M Buy
154,303
+1,093
+0.7% +$135K 0.01% 1491
2015
Q1
$18.3M Buy
153,210
+86,980
+131% +$9.66M 0.01% 1534
2014
Q4
$7M Buy
66,230
+2,789
+4% +$295K ﹤0.01% 2399
2014
Q3
$6.53M Sell
63,441
-7,403
-10% -$750K ﹤0.01% 2403
2014
Q2
$6.64M Buy
70,844
+11,470
+19% +$1.02M ﹤0.01% 2409
2014
Q1
$5.31M Buy
59,374
+11,341
+24% +$924K ﹤0.01% 2526
2013
Q4
$3.68M Buy
48,033
+9,007
+23% +$664K ﹤0.01% 2870
2013
Q3
$2.79M Buy
39,026
+19,832
+103% +$1.41M ﹤0.01% 2956
2013
Q2
$1.39M Buy
+19,194
New +$1.41M ﹤0.01% 3436

Other funds holding CHE

Morgan Stanley's CHE Position: Q2 2026 in Review

Morgan Stanley increased its Chemed (CHE) stake by 2.3% in Q2 2026, buying an estimated $2.21M and bringing the position to 232,302 shares worth $108M. The position accounts for 0.01% of the portfolio, ranked #1503.

Morgan Stanley first reported a position in CHE in Q2 2013 and has held it in 53 quarters since. The position peaked at $267M in Q1 2024. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Morgan Stanley held 232,302 shares of Chemed worth $108M as of Q2 2026.
  • Morgan Stanley bought 5,253 Chemed shares in Q2 2026, an estimated $2.21M.
  • Chemed made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #1503 holding.
  • Morgan Stanley first reported a position in Chemed in Q2 2013 and has held it in 53 quarters since.
  • Morgan Stanley's Chemed position peaked at $267M in Q1 2024.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.